Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

GF60949840

Beryllium

wire reel, 0.1m, diameter 0.85mm, annealed and clean, 99%

Synonym(s):

Beryllium, BE005129, Glucinium

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
Be
CAS Number:
7440-41-7
Molecular Weight:
9.01
MDL number:
MFCD00134032
UNSPSC Code:
12141501
PubChem Substance ID:
329809195
NACRES:
NA.23

Assay

99%

form

wire

autoignition temp.

1198 °F

manufacturer/tradename

Goodfellow 609-498-40

resistivity

4.46 μΩ-cm, 20°C

L × diam.

0.1 m × 0.85 mm

bp

2970 °C (lit.)

mp

1278 °C (lit.)

density

1.85 g/mL at 25 °C (lit.)

SMILES string

[Be]

InChI

1S/Be

InChI key

ATBAMAFKBVZNFJ-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Pictograms

Skull and crossbonesHealth hazard
GHS06,GHS08

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Oral - Carc. 1B - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 1

Storage Class Code

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Kristin J Cummings et al.
Environmental health perspectives, 117(8), 1250-1256 (2009-08-13)
Although chronic beryllium disease (CBD) is clearly an immune-mediated granulomatous reaction to beryllium, acute beryllium disease (ABD) is commonly considered an irritative chemical phenomenon related to high exposures. Given reported new cases of ABD and projected increased demand for beryllium
A Seidler et al.
Occupational medicine (Oxford, England), 62(7), 506-513 (2012-06-19)
The relevance of beryllium sensitization testing for occupational health practice and prevention is unclear. To analyse the natural course of beryllium sensitization and clarify the prognosis following cessation of exposure among sensitized workers. An electronic literature search was conducted in
John R Balmes et al.
American journal of respiratory and critical care medicine, 190(10), e34-e59 (2014-11-15)
Beryllium continues to have a wide range of industrial applications. Exposure to beryllium can lead to sensitization (BeS) and chronic beryllium disease (CBD). The purpose of this statement is to increase awareness and knowledge about beryllium exposure, BeS, and CBD.
Linus H Santo Tomas
Current opinion in pulmonary medicine, 15(2), 165-169 (2009-06-18)
This review aims to present the clinician with a synthesis of recent studies that have enhanced our understanding of the epidemiology and pathogenesis of beryllium hypersensitivity (BeH) and chronic beryllium disease (CBD). Lower occupational limit levels to beryllium exposure and
L Mangin-Thro et al.
Nature communications, 6, 7705-7705 (2015-07-04)
The pseudo-gap phenomenon in copper oxide superconductors is central to any description of these materials as it prefigures the superconducting state itself. A magnetic intra-unit-cell order was found to occur just at the pseudo-gap temperature in four cuprate high-Tc superconducting
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service